Scripps 36th Annual New Treatments in Chronic Liver Disease 2022 (CME VIDEOS)

Educational Objectives

After attending this live activity, participants should be able to:
• Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis and reproductive health, and chronic liver disease.
• Review vascular disorders and coagulation management principles for patients with chronic liver disease.
• Summarize guidelines on NAFLD (AGA), DILI and hemochromatosis (ACG) and non-invasive markers of fibrosis (EASL).
• Evaluate drugs in development for PBC and PSC.
• Employ strategies for treating and managing ascites and hepatorenal syndrome.
• Describe advances in HCC therapy and management of acute-on-chronic liver disease.

Target Audience

• Hepatologists
• Gastroenterologists
• Infectious Disease Specialist

Topics:

• ACG Guidelines for DILI and Hemochromatosis – Kris Kowdley, MD
• Acute-on-Chronic Liver Disease – Timothy Morgan, MD
• Advanced Endoscopy in Liver Disease Patients – Matthew Skinner, MD
• Advances in HCC – Catherine Frenette, MD
• AGA Guidelines for NAFLD – Mazen Noureddin, MD
• Autoimmune Hepatitis – John Vierling, MD
• Debate- Use of Semaglutide for Obese Patients with NAFLD – Paul J. Pockros, MD, Michael Charlton, MD
• EASL Guidelines for Non-Invasive Testing – Michael Charlton, MD
• Panel Discussion1
• Panel Discussion2
• Panel Discussion3
• Reproductive Health and Chronic Liver Disease – Norah Terrault, MD
• Update on Management of Ascites and HRS – Florence Wong, MD
• Vascular Disorders and Anticoagulation – Patrick Northup, MD
• Viral Hepatitis B and C – Julio Gutierrez, MD
• When to Refer for Liver Transplantation – Adam Deising, MD
• WILLIAM S. HAUBRICH LECTURE- What’s New in PBC and PSC- – Kris Kowdley, MD